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ABSTRACT 
Background: In our previous studies conducted on Ardisia crispa roots, it was shown that 
Ardisia crispa root inhibited inflammation-induced angiogenesis in vivo. The present study 
was conducted to identify whether the anti-angiogenic properties of Ardisia crispa roots was 
partly due to either cyclooxygenase (COX) or/and lipoxygenase (LOX) activity inhibition in 
separate in vitro studies. Methods: Benzoquinonoid fraction (BQ) was isolated from hexane 
extract by column chromatography, and later analyzed by using gas chromatography–mass 
spectrometry (GC-MS). Anti-angiogenic effect was studied on mouse sponge implantation 
assay. Ardisia crispa ethanolic rich fraction (ACRH), quinone-rich fraction (QRF) and BQ 
were screened for COX assay to evaluate their selectivity towards two isoforms (COX-1 and 
COX-2), The experiment on soy lipoxygenase (LOX) inhibitory assay was also performed to 
determine the inhibitory effect of ACRH, QRF and BQ on soy LOX. Results: BQ was 
confirmed to consist of 2-methoxy-6-undecyl-1,4-benzoquinone, when compared with 
previous data. Antiangiogenesis study exhibited a reduction of mean vascular density (MVD) 
in both ACRH and QRF, compared to control. In vitro study showed that both ACRH and 
QRF inhibited both COX-1 and COX-2, despite COX-2 inhibition being slightly higher than 
COX-1 in BQ. On the other hand, both ACRH and QRF were shown to have poor LOX 
inhibitory activity, but not BQ. Conclusions: In conclusion, ACRH and QRF might possibly 
exhibit its anti-angiogenic effect by inhibiting cyclooxygenase. However, both of them were 
shown to possess poor LOX inhibitory activity. On the other hand, BQ displayed selectivity 
to COX-2 inhibitory property as well as LOX inhibitory effect. 
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